Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced the completion of its acquisition of CASE Emergency Systems (“CASE”). The acquisition is designed to contribute to Knightscope’s sales strategy based on CASE’s…
Houston-headquartered Freight Technologies Inc. is an AI-driven technology developer focused on supporting the commercial trucking industry through efficient and transparent operations Recent discussion of cross-border traffic infrastructure projects by Mexico’s and the United States’ ambassadors…
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced proof-of-concept data supporting the therapeutic potential of SPC-14 as a treatment for Alzheimer’s disease, as demonstrated…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is featured in a recent Investorideas.com special report. Investorideas.com is a leading investor news resource covering EV and automotive stocks. According to the report, the…
Commonly used surveillance cameras employ AI-powered facial recognition technology that can compromise privacy and lead to biased decisions Lidar may hold the key to privacy-focused solutions by feeding purely behavior-based and biometric-free data into systems…
Flora Growth Corp. (NASDAQ: FLGC), a global cannabis cultivator, product manufacturer and distributor, is measuring its success in rapidly rising revenues brought on by strategic acquisitions and the expanding international movement of its brands. “The…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received approval from the U.S. Bankruptcy Court to move forward on its acquisition of Electric Last Mile Solutions (“ELMS”) assets; ELSM is an electric…
Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness The antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF) today announced that construction has commenced at the company’s Core RNG Expansion Project at Fraser Valley Biogas. Located in Abbotsford, British Columbia, Fraser Valley Biogas (“FVB”) has been in operation…
Flora Growth is a global cannabis company building a connected, design-led collective of plant-based wellness and lifestyle brands The company’s portfolio of brands is designed to deliver the most compelling customer experiences in the world…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), and its Robot Roadshow are spending the day in Dallas. The roadshow is a free, engaging experiential event that is designed to provide potential…
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced that it will provide a business update and release its financial results for the third quarter of 2022 following the…
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has entered into an agreement with Columbia University to extend its current research partnership efforts. The agreement outlines…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has been conducting an ongoing drilling program at…
Eloro Resources is an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru, and Quebec Company released positive results from 21 diamond drill holes at Iska Iska Bolivia…
The Renewable Natural Gas (“RNG”) market is forecast to grow to an annual market size of $72.13 billion by 2027 EverGen purchased a 66% stake in Albert-based agri operation, GrowTEC for a gross consideration of…
Correlate’s strategic investments in clean electrification solutions and commercial solar infrastructure have earned the company a growing customer base, and an opportunity pipeline of over $100 million in commercial projects The company recognizes the rise…
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was featured in a recent BioWorld(TM) MedTech article. “HeartBeam Inc. has been awarded a patent for…
Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is currently conducting a potentially pivotal global phase 2 clinical trial in humans to test the effectiveness of its anti-glioblastoma (“GBM”) drug candidate – Berubicin. Testing of Berubicin…